Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028273 · ClinicalTrials.gov registry record
Hippocampal Neurogenesis in Human Subjects
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 14
- Enrollment target
NCT02028273 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT02028273 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This study is being done to measure the number of brain cells that grow in the brain throughout our lives while determining an effective way to complete this with an MRI (Magnetic Resonance Imaging) scanner. The number of these brain cells may be affected by cocaine use. Researchers are trying to understand the long-term effects of cocaine use on the brain.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02028273
The ClinicalTrials.gov registry entry for NCT02028273 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02028273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02028273 about?
NCT02028273 is a clinical study titled "Hippocampal Neurogenesis in Human Subjects". This study is being done to measure the number of brain cells that grow in the brain throughout our lives while determining an effective way to complete this with an MRI (Magnetic Resonance Imaging) scanner. The number of these brain cells may be affected by cocaine use. Researchers are trying to un...
What is the current status of trial NCT02028273?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2012-05. Estimated completion is 2018-01.
Who is sponsoring clinical trial NCT02028273?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.